🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of FODMAP Diet on Pain, Quality of Life, and Sexual Function in Women With Pelvic Endometriosis and Gastrointestinal Symptoms

RecruitingNAAges 18 Years - 45 YearsFemaleFondazione IRCCS Ca' Granda, Ospedale Maggiore Po…
NCT07590895 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The main objective of the study is to assess whether a dietary regimen based on the principles of the FODMAP diet, compared with the current treatment programme which does not include specific dietary recommendations, can improve pain symptoms in patients with symptomatic endometriosis and intestinal symptoms (i.e. bloating, nausea, constipation, diarrhoea and vomiting) attributable to irritable bowel syndrome, compared with a control group

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 45 years * BMI between 18.5 and 24.9, * Surgical, clinical or instrumental diagnosis of endometriosis * Presence of bowel symptoms (i.e., bloating, nausea, constipation, diarrhea, and vomiting) referable to irritable bowel syndrome, on estro-progestin or progestin treatment or in the absence of hormonal treatment Exclusion Criteria: * Associated conditions that may cause pelvic pain independent of the presence of endometriosis (e.g., pelvic varices and salpingitis outcomes) * chronic inflammatory bowel disease (Crohn's disease or ulcerative rectocolitis). * patients with obstructive uropathy, subocclusive intestinal stenosis * complex adnexal masses or typical endometriomas greater than 5 cm in diameter. * women who are obese (BMI ≥ 30) or underweight (BMI \< 18) * women on vegetarian-vegan dietary regimens, * women with metabolic diseases that require specific dietary indications such as in the case of diabetes and celiac disease.
💊

What it tests

  • FODMAP diet
📍

Where

1 site
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy